CBO Keeps Idea Of Mandatory Rx Rebates For Medicare Part D Low-Income Members In Play
This article was originally published in The Pink Sheet Daily
Executive Summary
In a report on options for reducing the deficit, the Congressional Budget Office returns to the idea of mandating minimum rebates of 23.1% on drugs used by low-income beneficiaries, including dual eligibles, in Medicare Part D.
You may also be interested in...
Medicare Part D Rebate Prospects Advancing In Debt Talks? PhRMA Ratchets Up Opposition
Threat of mandatory rebates is "real," CEO Castellani says.
Medicare Part D Rebate Prospects Advancing In Debt Talks? PhRMA Ratchets Up Opposition
Threat of mandatory rebates is "real," CEO Castellani says.
What's Not In The Budget: Deficit Panel's Proposal For Rebates On Drugs Used By Dual-Eligibles
The president's National Commission on Fiscal Responsibility and Reform suggested that mandatory rebates for drugs used by Medicaid/Medicare dual eligibles would go a long way in offsetting a proposed "doc fix."